Search

Brett D Lindenbach

from North Haven, CT
Age ~56
Get Report
Also known as:
Brett David Lindenbach, Brett P Lindenbach, Brett D Lindenback, Bret Lindenbach, Brett David H
Phone and address:
9 Marlborough Rd, North Haven, CT 06473
Related to:
Le Ann Le, 77
Connected to:
Allison M Linden, 43Alvin P Linden, 80Alycia M Linden, 35Andrea R Linden, 48Barbara J Lindenberg, 69Barney Linden, 28Blue H Linden, 72Brian W Lindenborn, 59Brittany L Linden, 38Cara Linden, 59

Brett Lindenbach Phones & Addresses

  • 9 Marlborough Rd, North Haven, CT 06473
  • 60 Killdeer Rd, Hamden, CT 06517 (203) 891-6910
  • 216 Bishop St, New Haven, CT 06511 (203) 745-4696
  • 500 63Rd St, New York, NY 10021
  • 5517 Old Middleton Rd, Madison, WI 53705 (608) 232-0207
  • 6709 Century Ave, Middleton, WI 53562 (608) 836-7429
  • 6128 Waterman Ave, Saint Louis, MO 63112 (314) 726-5531
  • Naperville, IL

Business Records

Name / Title
Company / Classification
Phones & Addresses
Brett Lindenbach
Phd Full
Rockefeller University
Research · Noncommercial Medical Research Hospital · Noncommercial Research Organization College/University · Noncommercial Research Organization · College/University · Colleges, Universities, and Pr
1230 York Ave, New York, NY 10065
123 York Ave, New York, NY 10021
(212) 327-7511, (212) 327-8078, (212) 327-8666, (212) 327-8000

Publications

Us Patents

Infectious, Chimeric Hepatitis C Virus, Methods Of Producing The Same And Methods Of Use Thereof

View page
US Patent:
20060210969, Sep 21, 2006
Filed:
Mar 3, 2006
Appl. No.:
11/366839
Inventors:
Charles Rice - New York NY, US
Brett Lindenbach - New York NY, US
Matthew Evans - New York NY, US
Christopher Jones - New York NY, US
International Classification:
C12Q 1/70
C07H 21/04
C12N 7/00
C12N 15/86
C12N 5/06
US Classification:
435005000, 435069300, 435456000, 435235100, 435325000, 536023720
Abstract:
The present invention provides infectious recombinant Hepatitis C Viruses (HCV), and vectors, cells and animals comprising the same. The present invention provides methods of producing infectious recombinant HCV, and their use in identifying anti-HCV therapeutic agents, as well as sequences of HCV associated with HCV pathogenesis.

Infectious, Chimeric Hepatitis C Virus, Methods Of Producing The Same And Methods Of Use Thereof

View page
US Patent:
20100062419, Mar 11, 2010
Filed:
Oct 19, 2009
Appl. No.:
12/581597
Inventors:
Charles Rice - New York NY, US
Matthew J. Evans - New York NY, US
Brett D. Lindenbach - Hamden CT, US
Christopher Jones - New York NY, US
Assignee:
THE ROCKEFELLER UNIVERSITY - New York NY
International Classification:
C12Q 1/70
C12N 7/00
C07H 21/04
US Classification:
435 5, 4352351, 536 231
Abstract:
The present invention provides infectious recombinant Hepatitis C Viruses (HCV), and vectors, cells and animals comprising the same. The present invention provides methods of producing infectious recombinant HCV, and their use in identifying anti-HCV therapeutic agents, as well as sequences of HCV associated with HCV pathogenesis.
Control profile
Brett D Lindenbach from North Haven, CT, age ~56 Get Report